280 related articles for article (PubMed ID: 34540237)
1. Kidney Transplantation in Times of Covid-19: Decision Analysis in the Canadian Context.
Yanev I; Gagnon M; Cheng MP; Paraskevas S; Kumar D; Dragomir A; Sapir-Pichhadze R
Can J Kidney Health Dis; 2021; 8():20543581211040332. PubMed ID: 34540237
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Net Benefits of Adult Deceased Donor Kidney Transplantation for a Patient on the Preemptive Waiting List vs a Patient Receiving Dialysis.
Kiberd BA; Tennankore KK; Vinson AJ
JAMA Netw Open; 2022 Jul; 5(7):e2223325. PubMed ID: 35867058
[TBL] [Abstract][Full Text] [Related]
3. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
4. Optimal Sequencing of Deceased Donor and Live Donor Kidney Transplant Among Pediatric Patients With Kidney Failure.
Kiberd BA; Vinson A; Acott PD; Tennankore KK
JAMA Netw Open; 2022 Jan; 5(1):e2142331. PubMed ID: 34989796
[TBL] [Abstract][Full Text] [Related]
5. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
7. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
9. Renal transplantations in African Americans: a single-center experience of outcomes and innovations to improve access and results.
Modlin CS; Alster JM; Saad IR; Tiong HY; Mastroianni B; Savas KM; Zaramo CE; Kerr HL; Goldfarb D; Flechner SM
Urology; 2014 Jul; 84(1):68-76. PubMed ID: 24976221
[TBL] [Abstract][Full Text] [Related]
10. International Practices on COVID-19 Vaccine Mandates for Transplant Candidates.
Caliskan Y; Hippen BE; Axelrod DA; Schnitzler M; Maher K; Alhamad T; Lam NN; Anwar S; Kute V; Lentine KL
Kidney360; 2022 Oct; 3(10):1754-1762. PubMed ID: 36514724
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
[TBL] [Abstract][Full Text] [Related]
12. Kidney transplantation in the United States.
Cecka JM
Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Outcomes for kidney transplants at the National University Health System: comparison with overseas transplants.
Vathsala A
Clin Transpl; 2010; ():149-60. PubMed ID: 21696038
[TBL] [Abstract][Full Text] [Related]
15. OPTN/SRTR 2020 Annual Data Report: Kidney.
Lentine KL; Smith JM; Hart A; Miller J; Skeans MA; Larkin L; Robinson A; Gauntt K; Israni AK; Hirose R; Snyder JJ
Am J Transplant; 2022 Mar; 22 Suppl 2():21-136. PubMed ID: 35266618
[TBL] [Abstract][Full Text] [Related]
16. Antibody Responses after Two Doses of COVID-19 mRNA Vaccine in Dialysis and Kidney Transplantation Patients Recovered from SARS-CoV-2 Infection.
Cappuccilli M; Semprini S; Fabbri E; Fantini M; Bruno PF; Spazzoli A; Righini M; Flachi M; La Manna G; Sambri V; Mosconi G
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888612
[No Abstract] [Full Text] [Related]
17. Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada.
Oliver MJ; Thomas D; Balamchi S; Ip J; Naylor K; Dixon SN; McArthur E; Kwong J; Perl J; Atiquzzaman M; Singer J; Yeung A; Hladunewich M; Yau K; Garg AX; Leis JA; Levin A; Krajden M; Blake PG
J Am Soc Nephrol; 2022 Apr; 33(4):839-849. PubMed ID: 35264455
[TBL] [Abstract][Full Text] [Related]
18. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
[TBL] [Abstract][Full Text] [Related]
19. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
[TBL] [Abstract][Full Text] [Related]
20. Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
Charmetant X; Espi M; Benotmane I; Barateau V; Heibel F; Buron F; Gautier-Vargas G; Delafosse M; Perrin P; Koenig A; Cognard N; Levi C; Gallais F; Manière L; Rossolillo P; Soulier E; Pierre F; Ovize A; Morelon E; Defrance T; Fafi-Kremer S; Caillard S; Thaunat O
Sci Transl Med; 2022 Mar; 14(636):eabl6141. PubMed ID: 35103481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
